Brief: Bellicum Pharmaceuticals Inc - QTRLY Loss Per Share $0.13
11/08/2022 21:14
Aug 11 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES OPERATIONAL UPDATE
* BELLICUM PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.13
* BELLICUM PHARMACEUTICALS INC - PLANS TO PRESENT AN INTERIM
DATA
UPDATE ON BPX-603 IN FIRST HALF OF 2023
Source text for Eikon: ID:nGNXmmGh9
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview